Nidan Laboratories & Healthcare Limited Stock Price Today (NSE: NIDAN)
Nidan Laboratories & Healthcare Limited
Fundamental Score
Nidan Laboratories & Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nidan Laboratories & Healthcare Limited share price today is ₹14.20, down 2.41% on NSE/BSE as of 22 June 2026. Nidan Laboratories & Healthcare Limited (NIDAN) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹30.72 (Cr). The 52-week high for NIDAN share price is ₹23.60 and the 52-week low is ₹13.15. At a P/E ratio of 13.30x, NIDAN is currently trading below its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 2.92% and a debt-to-equity ratio of 0.18.
Nidan Laboratories & Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
Nidan Laboratories & Healthcare Limited share price chart: 1.07% return over the past month. 52-week high ₹23.60, 52-week low ₹13.15.
Nidan Laboratories & Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹14.00 | ₹14.20 | ₹13.20 | ₹14.20 | 5.00K (Cr) | |
| ₹14.00 | ₹14.55 | ₹14.00 | ₹14.55 | 9.00K (Cr) | |
| ₹13.15 | ₹15.00 | ₹13.15 | ₹14.40 | 5.00K (Cr) | |
| ₹13.90 | ₹14.20 | ₹13.75 | ₹14.20 | 7.00K (Cr) | |
| ₹14.00 | ₹14.10 | ₹13.80 | ₹14.10 | 6.00K (Cr) | |
| ₹14.60 | ₹14.60 | ₹14.25 | ₹14.25 | 2.00K (Cr) | |
| ₹13.95 | ₹14.35 | ₹13.75 | ₹14.05 | 11.00K (Cr) | |
| ₹15.55 | ₹15.55 | ₹14.95 | ₹14.95 | 2.00K (Cr) | |
| ₹15.60 | ₹15.60 | ₹15.60 | ₹15.60 | 6.00K (Cr) | |
| ₹13.75 | ₹13.90 | ₹13.75 | ₹13.90 | 5.00K (Cr) |
Nidan Laboratories & Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹14.00 | ₹14.20 | ₹13.20 | ₹14.20 | +1.43% | |
| ₹13.95 | ₹15.00 | ₹13.15 | ₹14.55 | +4.30% | |
| ₹13.75 | ₹15.60 | ₹13.75 | ₹14.95 | +8.73% | |
| ₹15.80 | ₹15.80 | ₹13.40 | ₹13.90 | -12.03% | |
| ₹15.00 | ₹17.50 | ₹15.00 | ₹17.50 | +16.67% | |
| ₹18.80 | ₹19.00 | ₹15.15 | ₹15.25 | -18.88% | |
| ₹23.60 | ₹23.60 | ₹18.55 | ₹18.65 | -20.97% | |
| ₹19.85 | ₹20.75 | ₹19.10 | ₹19.25 | -3.02% | |
| ₹18.25 | ₹19.50 | ₹17.85 | ₹19.50 | +6.85% | |
| ₹18.10 | ₹19.55 | ₹17.85 | ₹18.25 | +0.83% | |
| ₹20.80 | ₹20.80 | ₹17.30 | ₹18.10 | -12.98% | |
| ₹21.35 | ₹21.50 | ₹19.00 | ₹20.50 | -3.98% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nidan Laboratories & Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nidan Laboratories & Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NIDAN across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (29.75%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 13.30 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (30.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (24.60%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (22.52% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.18)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (57.04%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (2.92%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.17%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (2.76% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nidan Laboratories & Healthcare Limited vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Nidan Laboratories & Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
62.7/100 | ₹14.20₹14 | ₹30.72₹30.72 | 13.30Average 13.3 Average | 2.92%Poor 2.92% Poor | 6.17%Poor 6.17% Poor | 0.18Excellent 0.2 Excellent | 22.52%Excellent 22.52% Excellent | 2.76%Average 2.76% Average | 0.00% | |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1536.90₹1537 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1372.40₹1372 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹533.20₹533 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹518.00₹518 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹551.90₹552 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹275.20₹275 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1121.05₹1121 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹544.20₹544 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹303.00₹303 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹236.70₹237 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Nidan Laboratories & Healthcare Limited Quarterly Performance
Latest quarterly metrics for NIDAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
24.60%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
30.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
2.76%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
22.52%
Compounded annual net profit growth over 5 years
Nidan Laboratories & Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NIDAN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nidan Laboratories & Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nidan Laboratories & Healthcare Limited (NIDAN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Nidan Laboratories & Healthcare Limited
About NIDAN (Nidan Laboratories & Healthcare Limited)
Nidan Laboratories & Healthcare Limited (NIDAN) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Serv...ice Provider sector with a current market capitalisation of ₹30.72 (Cr). Nidan Laboratories & Healthcare Limited has delivered a Return on Equity (ROE) of 2.92% and a ROCE of 6.17%. The debt-to-equity ratio stands at 0.18, reflecting the company's capital structure. Investors tracking NIDAN share price can monitor key metrics including P/E ratio, promoter holding of 57.04%, and quarterly earnings growth.
Company Details
NIDAN Share Price: Frequently Asked Questions
What is the current share price of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited (NIDAN) trades at ₹14.20 on NSE. Market cap ₹30.72 (Cr). Educational data only.
What is the P/E ratio of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has a P/E of 13.30x vs industry average 39.28x.
What is the Bull Run score for Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has a Bull Run score of 62.7/100 based on 25+ financial parameters.
Does Nidan Laboratories & Healthcare Limited pay dividends?
Nidan Laboratories & Healthcare Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has ROE of 2.92%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has debt-to-equity of 0.18.
Is Nidan Laboratories & Healthcare Limited a good investment?
Bull Run gives Nidan Laboratories & Healthcare Limited a score of 62.7/100. This is not investment advice — consult a SEBI-registered advisor.